B

BioNote Inc
KRX:377740

Watchlist Manager
BioNote Inc
KRX:377740
Watchlist
Price: 4 620 KRW 2.67%
Market Cap: 471.2B KRW
Have any thoughts about
BioNote Inc?
Write Note

BioNote Inc
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

BioNote Inc
Cost of Revenue Peer Comparison

Comparables:
068270
302440
H
145020
P
214450
196170

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
B
BioNote Inc
KRX:377740
Cost of Revenue
-â‚©101.7B
CAGR 3-Years
-25%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Celltrion Inc
KRX:068270
Cost of Revenue
-â‚©1.5T
CAGR 3-Years
-23%
CAGR 5-Years
-28%
CAGR 10-Years
-31%
SK Bioscience Co Ltd
KRX:302440
Cost of Revenue
-â‚©227.3B
CAGR 3-Years
-20%
CAGR 5-Years
-36%
CAGR 10-Years
N/A
H
Hugel Inc
KOSDAQ:145020
Cost of Revenue
-â‚©81.7B
CAGR 3-Years
-7%
CAGR 5-Years
-7%
CAGR 10-Years
N/A
P
PharmaResearch Co Ltd
KOSDAQ:214450
Cost of Revenue
-â‚©85.6B
CAGR 3-Years
-29%
CAGR 5-Years
-23%
CAGR 10-Years
N/A
Alteogen Inc
KOSDAQ:196170
Cost of Revenue
-â‚©56.3B
CAGR 3-Years
-29%
CAGR 5-Years
-32%
CAGR 10-Years
N/A

See Also

What is BioNote Inc's Cost of Revenue?
Cost of Revenue
-101.7B KRW

Based on the financial report for Dec 31, 2023, BioNote Inc's Cost of Revenue amounts to -101.7B KRW.

What is BioNote Inc's Cost of Revenue growth rate?
Cost of Revenue CAGR 3Y
-25%

Over the last year, the Cost of Revenue growth was 27%. The average annual Cost of Revenue growth rates for BioNote Inc have been -25% over the past three years .

Back to Top